Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor David Elliott

Newcastle AuthorsTitleYearFull text
Caroline Dalgliesh
Saad Aldalaqan
Christian Atallah
Dr Andrew Best
Dr Emma Scott
et al.
An ultra-conserved poison exon in the Tra2b gene encoding a splicing activator is essential for male fertility and meiotic cell division2025
Kayla Bastian
Maggie Orozco Moreno
Huw Thomas
Dr Kirsty Hodgson
Laura Wilson
et al.
FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors2025
Professor David Elliott
Modulation of Neurexins Alternative Splicing by Cannabinoid Receptors 1 (CB1) Signaling2025
Caroline Dalgliesh
Farimah Ghorbani
Dr Adam Wollman
Professor David Elliott
Ultra-Conserved Poison Exons Enable Rapid and Safe Splicing Factor Gene Expression Switches: A Hypothesis2025
Chile Siachisumo
Dr Sara Luzzi
Saad Aldalaqan
Dr Gerald Hysenaj
Caroline Dalgliesh
et al.
An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression2024
Dr Ingrid Ehrmann
Professor David Elliott
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development2024
Rob Atkinson
Dr Maria Georgiou
Dr Chunbo Yang
Marina Moya Molina
Dr Joseph Collin
et al.
PRPF8-mediated dysregulation of hBrr2 helicase disrupts human spliceosome kinetics and 5´-splice-site selection causing tissue-specific defects2024
Dr Kirsty Hodgson
Maggie Orozco Moreno
Emily Archer Goode
Dr Rebecca Garnham
Karen Livermore
et al.
Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone2024
Maggie Orozco Moreno
Dr Kirsty Hodgson
Amirah Nabilah
Meera Murali
Jess Peng
et al.
Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells2024
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2024
Caroline Dalgliesh
Professor David Elliott
Clustered variants in the 5′ coding region of TRA2B cause a distinctive neurodevelopmental syndrome2023
Rahul Advani
Dr Sara Luzzi
Dr Emma Scott
Caroline Dalgliesh
Dr Jennifer Munkley
et al.
Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer2023
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.
ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2023
Dr Kirsty Hodgson
Maggie Orozco Moreno
Dr Emma Scott
Rebecca Garnham
Karen Livermore
et al.
The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer2023
Dr Emma Scott
Dr Kirsty Hodgson
Kat Cheung
Edward Yo
Laura Wilson
et al.
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth2023
12345678